CAAS Capital Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-900
Closed -$289K 440
2024
Q2
$289K Buy
+900
New +$292K 0.09% 136
2024
Q1
Sell
-2,500
Closed -$677K 566
2023
Q4
$677K Buy
2,500
+1,100
+79% +$272K 0.07% 235
2023
Q3
$344K Buy
+1,400
New +$383K 0.02% 439
2023
Q1
Sell
-2,500
Closed -$600K 796
2022
Q4
$600K Sell
2,500
-9,800
-80% -$2.19M 0.04% 367
2022
Q3
$2.26M Buy
+12,300
New +$2.45M 0.11% 263
2020
Q4
Sell
-89,700
Closed -$11.2M 864
2020
Q3
$11.2M Buy
89,700
+19,700
+28% +$2.44M 0.26% 83
2020
Q2
$6.79M Buy
+70,000
New +$7.28M 0.22% 105

Other funds holding HCA

CAAS Capital Management's HCA Position: Q4 2022 in Review

CAAS Capital Management sold out of HCA Healthcare (HCA) in Q4 2022, closing a stake of 6,600 shares — an estimated $1.48M sold.

CAAS Capital Management first reported a position in HCA in Q3 2022 and held it in 1 quarter. The position peaked at $1.21M in Q3 2022. 962 funds tracked by Wall St. Rank hold HCA as of Q4 2022.

  • CAAS Capital Management reported no remaining HCA Healthcare position as of Q4 2022 after selling out during the quarter.
  • CAAS Capital Management sold 6,600 HCA Healthcare shares in Q4 2022, an estimated $1.48M.
  • CAAS Capital Management first reported a position in HCA Healthcare in Q3 2022 and held it in 1 quarter.
  • CAAS Capital Management's HCA Healthcare position peaked at $1.21M in Q3 2022.
  • 962 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2022.

Based on CAAS Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.